Cost-effectiveness of PCV20 to Prevent Pneumococcal Disease in the Pediatric Population: A German Societal Perspective Analysis-Reference-Cited by-同舟云学术

Cost-effectiveness of PCV20 to Prevent Pneumococcal Disease in the Pediatric Population: A German Societal Perspective Analysis

Published:2024-05-11 Issue:6 Volume:13 Page:1333-1358
ISSN:2193-8229
Container-title:Infectious Diseases and Therapy
language:en
Short-container-title:Infect Dis Ther

Author:

Ta An^ORCID,Kühne Felicitas^ORCID,Laurenz Maren,von Eiff Christof,Warren Sophie,Perdrizet Johnna^ORCID

Funder

Pfizer

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40121-024-00977-4.pdf

Reference81 articles.

1. Ta A, et al. Cost-effectiveness of PCV20 to prevent pneumococcal disease in the pediatric population—a German societal perspective analysis. medRxiv. 2024.03.14.24304296; https://doi.org/10.1101/2024.03.14.24304296.

2. Dadonaite, B. and M. Roser, Pneumonia. 2019. OurWorldInData.org.

3. European Centre for Disease Prevention and Control, Factsheet about pneumococcal disease. 2023.

4. Ganaie F, et al. A new pneumococcal capsule type, 10D, is the 100th serotype and has a large cps fragment from an oral streptococcus. mBio. 2020. https://doi.org/10.1128/mbio.00937-20.

5. World Health Organization. Pneumococcal Disease. [cited 2023 June]; Available from: https://www.who.int/teams/health-product-policy-and-standards/standards-and-specifications/vaccine-standardization/pneumococcal-disease.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-Effectiveness Analysis of Routine Childhood Immunization with 20-Valent versus 15-Valent Pneumococcal Conjugate Vaccines in Germany;Vaccines;2024-09-12